In this downloadable audio from a live Webinar, gain clinical insights on new HIV data presented at IAS 2019. Areas of focus include NTD risk in pregnancy, PrEP, first-line therapy, switch strategies, and STI prevalence among MSM.
Updated first-line and switch data reinforce the noninferiority of DTG/3TC compared with 3-drug regimens. How will these results affect practice? Here’s my take.
Updated information regarding neural tube defects and weight gain with ART was presented at IAS 2019. These data are important to my practice. Here’s why.